AI Can Help Screen For Vision-Destroying Diabetic Eye Disease

Follow Drugslib on

By Dennis Thompson HealthDay Reporter

Medically reviewed by Drugs.com

via HealthDay

WEDNESDAY, July 16, 2025 — A new AI-powered retina tracker can help doctors screen for a vision-destroying diabetic eye disease, researchers say.

The Simple Mobile AI Retina Tracker (SMART) program achieved greater than 99% accuracy in screening for diabetic retinopathy, researchers reported Monday at the annual meeting of The Endocrine Society in San Francisco.

The program “uses cutting-edge deep learning algorithms to analyze retinal fundus images quickly and accurately, on internet-powered devices including basic smartphones,” researcher Jansi Rani Sethuraj of the University of Texas Health Sciences Center in Houston said in a news release.

“The SMART AI application enables ophthalmologists to streamline patient screening, empowers primary care providers to incorporate eye exams into routine visits, and expands access to high-quality retinal assessments in regions lacking specialized ophthalmic care,” Sethuraj added.

Diabetic retinopathy is a condition in which leaky blood vessels damage a patient’s retina, the light-sensing wall of tissue that lines the back of the eye.

It’s a leading cause of preventable blindness that affects more than 100 million people around the world, researchers said in background notes.

To create the program, researchers trained an artificial intelligence (AI) model on several thousand retinal images from a diverse group of patients spanning six continents.

Researchers then tested the AI on another set of images and found it could detect diabetic retinopathy nearly all the time, with a processing speed of less than one second per image.

The tracker also was able to distinguish diabetic retinopathy from other eye diseases, researchers added.

“By democratizing eye care through universally accessible mobile technology, this innovation has the potential to screen billions globally, reducing vision loss from diabetic retinopathy while transforming healthcare delivery systems,” researcher Dr. Elangovan Krishnan with AIM Doctor in Houston said in a news release.

“This research proves that AI can be a force for good, bridging gaps in care and bringing hope to millions at risk of losing their sight,” he added.

Findings presented at medical meetings should be considered preliminary until published in a peer-reviewed journal.

Sources

  • The Endocrine Society, news release, July 14, 2025

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2025-07-17 00:00

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords